Varga SM - Search Results

1

Protective and pathologic roles of the immune response to mouse hepatitis virus type 1: implications for severe acute respiratory syndrome.

Khanolkar A, Hartwig SM, Haag BA, Meyerholz DK, Epping LL, Haring JS, Varga SM, Harty JT. Khanolkar A, et al. Among authors: varga sm. J Virol. 2009 Sep;83(18):9258-72. doi: 10.1128/JVI.00355-09. Epub 2009 Jul 1. J Virol. 2009. PMID: 19570864 Free PMC article.

2

RSV-induced immunopathology: dynamic interplay between the virus and host immune response.

Varga SM, Braciale TJ. Varga SM, et al. Virology. 2002 Apr 10;295(2):203-7. doi: 10.1006/viro.2002.1382. Virology. 2002. PMID: 12033778 Free article. Review. No abstract available.

3

In vivo generation of pathogen-specific Th1 cells in the absence of the IFN-gamma receptor.

Haring JS, Badovinac VP, Olson MR, Varga SM, Harty JT. Haring JS, et al. Among authors: varga sm. J Immunol. 2005 Sep 1;175(5):3117-22. doi: 10.4049/jimmunol.175.5.3117. J Immunol. 2005. PMID: 16116201

4

Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction.

Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. Ramaswamy M, et al. Among authors: varga sm. Virology. 2006 Jan 20;344(2):328-39. doi: 10.1016/j.virol.2005.09.009. Epub 2005 Oct 10. Virology. 2006. PMID: 16216295 Free article.

5

CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.

Olson MR, Varga SM. Olson MR, et al. Among authors: varga sm. J Immunol. 2007 Oct 15;179(8):5415-24. doi: 10.4049/jimmunol.179.8.5415. J Immunol. 2007. PMID: 17911628

6

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM. Castilow EM, et al. Among authors: varga sm. Immunol Res. 2007;39(1-3):225-39. doi: 10.1007/s12026-007-0071-6. Immunol Res. 2007. PMID: 17917067 Review.

7

Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.

Castilow EM, Olson MR, Meyerholz DK, Varga SM. Castilow EM, et al. Among authors: varga sm. J Virol. 2008 Mar;82(5):2196-207. doi: 10.1128/JVI.01949-07. Epub 2007 Dec 19. J Virol. 2008. PMID: 18094193 Free PMC article.

8

IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.

Castilow EM, Meyerholz DK, Varga SM. Castilow EM, et al. Among authors: varga sm. J Immunol. 2008 Feb 15;180(4):2376-84. doi: 10.4049/jimmunol.180.4.2376. J Immunol. 2008. PMID: 18250447

9

Regulation of cytokine production by virus-specific CD8 T cells in the lungs.

Fulton RB, Olson MR, Varga SM. Fulton RB, et al. Among authors: varga sm. J Virol. 2008 Aug;82(16):7799-811. doi: 10.1128/JVI.00840-08. Epub 2008 Jun 4. J Virol. 2008. PMID: 18524828 Free PMC article.

10

Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

Olson MR, Varga SM. Olson MR, et al. Among authors: varga sm. Expert Rev Vaccines. 2008 Oct;7(8):1239-55. doi: 10.1586/14760584.7.8.1239. Expert Rev Vaccines. 2008. PMID: 18844597 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters